Hemorrhagic transformation in acute ischemic stroke. Potential contributing factors in the European Cooperative Acute Stroke Study

BACKGROUND AND PURPOSE

Recent studies suggest that thrombolytic therapy may be of benefit to patients with acute ischemic stroke. However, the treatment also carries a significant risk of hemorrhagic transformation (HT). The purpose of this study was to select potential contributors to HT.

METHODS

We provide an explanatory analysis of the European Cooperative Acute Stroke Study (ECASS) data. ECASS was a multicenter, placebo-controlled, randomized trial of recombinant tissue plasminogen activator in ischemic stroke, within 6 hours of symptom onset, which enrolled 620 patients. HTs were classified into either hemorrhagic infarction or parenchymal hemorrhage according to their CT scan appearance. We used logistic regression analysis to select potential contributing factors to each type of HT.

RESULTS

The severity of initial clinical deficit (odds ratio [OR], 2.5; 95% confidence interval [CI], 1.6 to 4.0) and the presence of early ischemic changes on CT scan (OR, 3.5; 95% CI, 2.3 to 5.3) were associated with increased risk of hemorrhagic infarction. Increasing age (in decades; OR, 1.3; 95% CI, 1.0 to 1.7) and treatment with recombinant tissue plasminogen activator (OR, 3.6; 95% CI, 2.1 to 6.1) were related to the risk of parenchymal hemorrhage.

CONCLUSIONS

Since all potential contributing factors are readily discernible upon hospital admission, they should be used to improve selection of patients into future studies.

[Malignant endovascular large-cell lymphoma: disclosing central nervous system involvement confirmed by cerebral biopsy]

Intravascular malignant lymphomatosis (IML) is characterised by proliferation of tumoral cells within small vessels. Angiotropic large cell lymphoma commonly affects the central nervous system and the skin, although any organ may be involved. Few cases are diagnosed ante mortem. We report a new case of IML in a 62-year-old woman who presented with the main clinical features of central nervous system involvement: cerebrovascular events, epileptic seizures, subacute dementia and spinal cord syndrome. Cranial magnetic resonance imaging demonstrated increased periventricular signal on T2-weighted images. Diagnosis was established by brain biopsy. Despite corticosteroid and radiation therapy no improvement occurred and the patient died 14 months after the onset of the first symptoms.

Asymptomatic cerebral embolic signals in patients with carotid stenosis. Correlation with appearance of plaque ulceration on angiography

BACKGROUND AND PURPOSE

Asymptomatic cerebral emboli may be detected in patients with carotid stenosis by transcranial Doppler ultrasonography of the middle cerebral artery (MCA). The aim of this study was to determine the angiographic correlates of such embolic signals.

METHODS

Doppler signals from 48 MCAs in 26 patients with carotid stenosis that was either symptomatic (n = 20) or asymptomatic (n = 6) were recorded for 40 minutes. The grade of carotid stenosis and the ulcerated or nonulcerated appearance of the plaque were assessed using the criteria of the North American Symptomatic Carotid Endarterectomy Trial.

RESULTS

Embolic signals were detected in 8 MCAs from 7 patients; 4 (50%) of these MCAs were clinically symptomatic compared with 16 (40%) without embolic signal. Although there was a trend toward more severe stenosis in the cases with embolic signals, this was not significant (mean +/- SD, 67 +/- 29% versus 55 +/- 36%). In contrast, an image of ulceration was found on ipsilateral carotid angiography in 5 cases (63%) with embolic signals and in only 9 cases (23%) without embolic signals (odds ratio, 5.74; 95% confidence interval, 1.15 to 28.79, by multivariate regression analysis).

CONCLUSIONS

This study demonstrates that the occurrence of embolic signals in patients with carotid stenosis is associated with the appearance of plaque ulceration on angiography.

The functional anatomy of attention in humans: cerebral blood flow changes induced by reading, naming, and the Stroop effect

We measured changes in regional cerebral blood flow (rCBF) induced by reading, naming, and the Stroop effect in 12 right-handed normal volunteers. rCBF was quantified with a single-photon emission computerized tomograph after intravenous injection of 133Xe. Data were analyzed using predetermined regions of interest and a linear model. A significant relative activation was revealed in the right superior mesial frontal region during the Stroop effect.

[Effects of captopril on the cerebral blood flow in the hypertensive aged subjects]

Cerebral blood flow (CBF) was measured in 13 subjects (4 men and 9 women, mean age +/- SD = 63 +/- 7) with moderate, uncomplicated and untreated hypertension and 11 normotensive subjects (6 men and 5 women, mean age +/- SD = 66 +/- 5). A second CBF measurement was performed in hypertensive subjects after a 60 days randomized double blind treatment with either captopril, 75 mg a day (n = 8) or placebo (n = 5). CBF was quantified using the 133Xe inhalation technic and 16 stationary detectors by hemisphere. Comparison of CBF values between hypertensive subjects before treatment and normotensive subjects demonstrated a decrease of CBF in the hypertensive group (49 +/- 9 vs 72 +/- 14 ml/100 g/min; p < 0.001). After the trial the results in the captopril group showed a significant fall in systolic (p < 0.001) and diastolic (p < 0.05) blood pressure and a significant increase in CBF (60 +/- 14 vs 49 +/- 11 ml/100 g/min; p < 0.05). In the placebo group there was no change in blood pressure and CBF (Table). [Table; see text] Our results demonstrate a decrease in CBF of uncomplicated and untreated elderly hypertensive subjects. This decrease is reversible under chronic treatment with captopril.

[Guillain-Barré syndrome associated with cytomegalovirus infection after kidney transplantation]

The Guillain-Barré syndrome associated with cytomegalovirus infection is a recognized entity of unknown pathogenesis. We observed two characteristic cases with acute polyradiculoneuropathy which occurred after renal transplantation. Both patients fulfilled the diagnostic criteria for Guillain-Barré syndrome: tetraparesis with diffuse areflexia and moderate sensorial signs, high protein level in cerebrospinal fluid without cellular reaction, slow or blocked nerve conduction and partial cure after several months delay. In two-thirds of such cases, the syndrome follows an episode of infection. Cytomegalovirus has been recognized as a possible association. The demyelinating polyradiculoneuropathy induced by cytomegalovirus has been reported essentially in immunodepressed patients infected with the human immunodeficiency virus in whom a pathogenic role for cytomegalovirus in peripheral nerves has been suggested. In our two cases, the cytomegalovirus infection occurred before onset of the acute polyradiculoneuropathy. In both cases, specific IgM antibodies and clear IgG positivization occurred before the first signs of neurological impairment even though neither the virus nor specific antibodies could be concomitantly detected in the cerebrospinal fluid. Despite the frequency of cytomegalovirus infections in transplant recipients, to our knowledge, only 9 cases of Guillain-Barré syndrome after transplantation have been reported and the exact mechanism remains to be ascertained. These two cases suggest that the onset of the Guillain-Barré syndrome after renal transplantation was closely related to cytomegalovirus infection. Adequate measures should be taken to quickly diagnose such cases in order to instore rapid treatment for the polyradiculoneuropathy. In addition, this particular situation of post-transplantation onset might help better understand the exact role of cytomegalovirus infection in the Guillain-Barré syndrome.

[Antimitotic chemotherapy of supratentorial cerebral glioma in adults. Apropos of 56 cases]

Fifty-six patients with supratentorial gliomas were given chemotherapy (VM 26 and CCNU). Results were analyzed and compared to recent data from the medical literature. After the first great expectations the place of chemotherapy in the management of primary gliomas has now been more accurately delineated: it is an adjunctive therapy, complementary to surgery and radiotherapy. The contribution of chemotherapy, although slight, is unquestionable: in 2/3 of cases a significant improvement of the length of survival can be expected.